“…Of note, the authors did not observe an increase in circulating Flk1/Sca-1 double-positive cells and DiI-acLDL/ FITC-isolectin double-positive cells after ex vivo culture of spleen mononuclear cells after AdA-I transfer in mice transplanted with SR-BI-defi cient bone marrow, suggesting that expression of SR-BI in bone marrow is critical for EOC mobilization induced by HDL ( 166 ). Furthermore, the migratory capacity of bone marrow-derived EOC deficient in SR-BI in response to HDL was reduced as compared with EOCs containing SR-BI, and this was at least in part due to an impaired activation of ERKs and decreased NO production in SR-BI-defi cient EOCs ( 166 ). In vivo, SR-BI defi ciency in bone marrow abrogated the inhibitory effect of AdA-I transfer on allograft vasculopathy after paratopical transplantation of a common carotid artery of a female BALB/c donor mouse into the recipient male C57BL/6 mouse, which was paralleled by impaired endothelial regeneration and EOC incorporation in allografts ( 166 ).…”